Menopausal Hormone Therapy Positively Linked to Dementia
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, June 30, 2023 -- Menopausal hormone therapy is positively associated with all-cause dementia, even in women receiving treatment at age 55 years or younger, according to a study published online June 28 in The BMJ.
Nelsan Pourhadi, M.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleagues conducted a nationwide, nested case-control study involving 5,589 incident cases of dementia and 55,890 age-matched controls identified between 2000 and 2018 from a population of all Danish women to examine the association between use of menopausal hormone therapy and development of dementia.
The researchers found that people who had received estrogen-progestogen therapy had an increased rate of all-cause dementia compared with those who had never used treatment (hazard ratio, 1.24). Higher hazard ratios were seen with increasing durations of use, ranging from 1.21 to 1.72 for one year or less and for more than 12 years, respectively. For both continuous and cyclic regimens, estrogen-progestogen therapy was positively associated with development of dementia (hazard ratios, 1.31 and 1.24, respectively). In women who received treatment at age 55 years or younger, the associations persisted (hazard ratio, 1.24). When restricted to late-onset dementia and Alzheimer disease, the findings persisted (hazard ratios, 1.21 and 1.22, respectively).
"Further studies are warranted to explore if the observed association in this study between menopausal hormone therapy use and increased risk of dementia illustrates a causal effect," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease
FRIDAY, May 3, 2024 -- Among postmenopausal women with inflammatory bowel disease (IBD), there is no higher risk for cardiovascular disease (CVD) compared with women without IBD...
Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies
THURSDAY, May 2, 2024 -- The longitudinal Women's Health Initiative trials do not support hormone therapy for cardiovascular disease prevention, calcium and vitamin D...
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.